ACKR3 and cancer: ACKR3 generally is not considered a chemotactic receptor, however, addition of CXCL12 enhances ACKR3+/CXCR4+ cancer cell migration across endothelial cells toward CCL19 and CXCL13, chemokines expressed by endothelial cells inside the lymph nodes (47, 48).